ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 229 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,951,000 | +56.1% | 21,000 | 0.0% | 0.44% | +44.5% |
| Q3 2021 | $1,250,000 | -12.6% | 21,000 | 0.0% | 0.30% | -20.4% |
| Q2 2021 | $1,431,000 | -1.8% | 21,000 | 0.0% | 0.38% | -1.8% |
| Q1 2021 | $1,457,000 | +18.1% | 21,000 | +27.3% | 0.38% | -3.3% |
| Q3 2020 | $1,234,000 | +19.0% | 16,500 | 0.0% | 0.40% | +15.4% |
| Q2 2020 | $1,037,000 | +50.3% | 16,500 | 0.0% | 0.34% | +9.5% |
| Q1 2020 | $690,000 | -7.9% | 16,500 | 0.0% | 0.32% | +16.7% |
| Q4 2019 | $749,000 | -0.8% | 16,500 | 0.0% | 0.27% | -22.6% |
| Q3 2019 | $755,000 | -21.9% | 16,500 | 0.0% | 0.35% | -2.8% |
| Q2 2019 | $967,000 | +30.7% | 16,500 | 0.0% | 0.36% | +31.5% |
| Q1 2019 | $740,000 | – | 16,500 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |